Related Experiment Video
Updated: Jun 27, 2025

09:18
Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
Published on: April 4, 2025
516
Targeting Tumor Heterogeneity by Breaking a Stem Cell and Epithelial Niche Interaction Loop
Summary
Tumor heterogeneity challenges cancer therapies. A newly identified FGF-BMP7-INHBA signaling loop in breast cancer stem cells and their niche can be targeted to inhibit tumor progression and overcome drug resistance.
Area of Science:
- Cell Biology
- Cancer Research
- Developmental Biology
Background:
- Tumor heterogeneity presents a significant obstacle for effective cancer treatments.
- Interactions between cancer cell subpopulations and their stromal niche, influencing cancer stem cell behavior, are poorly understood.
Purpose of the Study:
- To elucidate the signaling pathways governing interactions between different cell populations in the mammary gland niche.
- To investigate the role of these interactions in both organ regeneration and breast cancer progression.
Main Methods:
- Investigated a positive feedback loop involving Fibroblast Growth Factor (FGF), Bone Morphogenetic Protein 7 (BMP7), and Inhibin Subunit Beta A (INHBA).
- Examined the reciprocal dependence between basal stem cells and luminal epithelium, regulated by stromal-epithelial FGF signaling.
Main Results:
- Identified an FGF-BMP7-INHBA signaling loop integrating mammary gland stem cells, luminal epithelial cells, and stromal fibroblasts.
- Demonstrated that targeting this loop inhibits both organ regeneration and breast cancer progression.
- Showcased the reciprocal dependence of basal stem cells and luminal epithelium mediated by BMP7 and INHBA, respectively.
Conclusions:
- The identified signaling loop is crucial for mammary gland development and cancer progression.
- Targeting this loop offers a potential strategy to overcome drug resistance driven by tumor heterogeneity.
- Findings have significant implications for developing novel targeted therapies for breast cancer.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Stem Cell Niche
5.1K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.1K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

